- Home
- LAKE vs COEP Comparison
LAKE vs COEP Comparison
Compare LAKE & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LAKE | COEP |
|---|---|---|
| Founded | 1982 | 2017 |
| Country | United States | United States |
| Employees | N/A | 7 |
| Industry | Industrial Specialties | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.1M | 72.7M |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | LAKE | COEP |
|---|---|---|
| Price | $9.08 | $10.47 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $16.33 | N/A |
| AVG Volume (30 Days) | ★ 79.3K | 37.1K |
| Earning Date | 04-16-2026 | 05-13-2026 |
| Dividend Yield | ★ 0.98% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $167,211,000.00 | N/A |
| Revenue This Year | $19.75 | N/A |
| Revenue Next Year | $6.94 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 2554.14 | N/A |
| 52 Week Low | $7.15 | $6.32 |
| 52 Week High | $20.50 | $21.41 |
Technical Indicators
Market Signals| Indicator | LAKE | COEP |
|---|---|---|
| Relative Strength Index (RSI) | 61.19 | 40.42 |
| Support Level | $8.70 | $6.80 |
| Resistance Level | $9.67 | $13.23 |
| Average True Range (ATR) | 0.44 | 0.97 |
| MACD | 0.16 | 0.04 |
| Stochastic Oscillator | 99.49 | 26.77 |
Price Performance
Historical ComparisonAbout LAKE Lakeland Industries Inc.
Lakeland Industries Inc manufactures and sells safety garments and accessories for the industrial protective clothing market. Its product segments include Disposables, Chemicals, Fire, Gloves, High Visibility, High-Performance Wear, and Wovens. Its customers include integrated oil, chemical/petrochemical, utilities, automobile, steel, glass, construction, smelting, munition plants, janitorial, pharmaceutical, and mortuaries, as well as scientific and medical laboratories. Its geographical segments include the United States, Latin America, Canada, Asia, Mexico, Europe (United Kingdom), and Other Foreign.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.